INSIGHTS ON DRUG DEVELOPMENT
-
What Information Does A CDMO Need To Deliver A Good Proposal?
Learn about the importance of sharing as much information as possible with your CDMO and how asking the right set of questions will ensure that services are fairly priced and timelines are accurate.
-
Establishing A Robust Workflow To Identify High-Performing Clones
Cell line development is a complex, labor intensive, and multistep process. Learn about a platform and host cell line that minimize the risk and timeline to develop high-performing clones.
-
Optimizing Lipid Formulations For Targeted RNA-LNP Applications
Learn about the considerations and challenges of using ionizable lipids, including the 5 types of lipids used for RNA delivery.
-
Gene Therapy CDMO: Choosing The Right One
The global gene therapy market is continuing to grow, but knowledge and expertise for commercialization is still limited. Explore the benefits of partnering with a specialized gene therapy CDMO.
-
SPR Assays To The Assess Similarity Between Innovator And Biosimilar Versions of Nivolumab (Opdivo®)9/2/2022
Learn more about developed and qualified SPR assays to characterize the binding and affinity of biosimilar and innovator nivolumab for all seven Fc gamma receptors, FcRn and PD-1.
-
Solutions For Sustainable Chemistry And Supply Chain7/31/2023
Examine how a CRDMO committed to delivering innovative solutions can help meet the unique needs and requirements of clients in the pharmaceutical, biotechnology, and other industries.
-
Reduce Timelines With Improved Analytical Techniques8/23/2022
With better analytical technologies, Waters and Sartorius are speeding the development process to bring new medicines and therapies to cancer patients faster and with fewer side effects.
-
Lowering The Lipid Barrier To RNA-LNP Therapeutics8/22/2023
Industry experts discuss current and future trends, formulating successful lipid compositions and navigating the constantly evolving genomic medicine landscape.
-
Improving Workflow Automation And Process Control10/17/2022
Learn about optimizing your T cell manufacturing process and reducing operating costs with rocking bioreactors using CTS OpTmizer T Cell Expansion SFM.
DRUG DEVELOPMENT SOLUTIONS
-
An industry-renowned instrument for monitoring GPCRs and ion channels
Powered by a new, optional high-speed EMCCD camera and the new Peak Pro 2 software module, the new FLIPR® Penta High-Throughput Cellular Screening System allows you to measure and analyze peaks of human-derived induced pluripotent stem cells (hiPSCs), differentiated into cardiomyocytes and neurons, up to 100 times per second and quickly cherry pick events such as Early Afterdepolarization-like events (EAD-like events), fibrillation, and irregular beating.
-
Accelerating the delivery of high quality, customized media with rapid set-up times, fast turnaround, and on-time delivery.
-
Lonza’s Drug Product Services delivers a holistic approach to DP development that prevents problems early and produces a product that is fit for purpose.
-
GO BEYOND with the SCIEX 7500 system, high performance triple quadrupole LC-MS/MS mass spectrometer
Enter a new era of sensitivity and LC-MS/MS innovation with the SCIEX 7500 system. GO BEYOND current limits of sensitivity, productivity targets, ruggedness and robustness challenges. Pioneer new discoveries with this innovation.
-
NFC-based personalization and enhanced touchscreen workflows provide walk-up usability
The SpectraMax® iD3 and iD5 Multi-Mode Microplate Readers measure absorbance, fluorescence, and luminescence. In addition, the iD5 reader measures TRF and FP and can be expanded to include TR-FRET, HTRF®, BRET, dual luciferase reporter assays with injectors, and western blot detection.